Iconthin Biotech, a specialist in Algae-Based Ingredients, is dedicated to pioneering sustainable biotechnology. Our focus extends from enterprise services to the development of consumer-facing products, including nutraceuticals, skincare, and functional foods. At the core of our cutting-edge technology is our commitment to innovation, underscored by our partnership with the renowned microalgae research team at the University of Toronto. We proudly introduce AlgaeAsta® - Leading with Natural Astaxanthin. Discover the power of AlgaeAsta® Astaxanthin, derived 100% from the microalgae Haematococcus pluvialis using the latest 3rd generation cultivation technology. Our natural astaxanthin outperforms its synthetic counterpart in terms of efficacy and safety, making it the right choice for health-conscious consumers. Join us in our journey to drive sustainable biotechnology and experience the benefits of AlgaeAsta®.
Looking for a particular Iconthin Biotech employee's phone or email?
The Iconthin Biotech annual revenue was $5 million in 2026.
Alvin C. is the Founder and CEO of Iconthin Biotech.
4 people are employed at Iconthin Biotech.
Iconthin Biotech is based in Toronto, Ontario.
The NAICS codes for Iconthin Biotech are [54, 54171, 541713, 5417, 541].
The SIC codes for Iconthin Biotech are [873, 87].